Patent-pending antibody allows easier tracking of treatment effectiveness
Scientists from NTU Singapore, the world’s No. 1 young university, have developed an antibody which boosts the survival chances for patients suffering from influenza and pneumonia.
Proven effective in lab tests, the antibody is now being made suitable for use in humans. The scientists are also using the new antibody to develop a diagnostic kit which can help doctors accurately track the recovery progress of flu and pneumonia patients.
The patent-pending antibody has generated much interest globally. Two biotech multi-national corporations, Abcam based in the United Kingdom and Adipogen International based in the United States, have won the rights to license the antibody. The two multinational companies will produce the antibody for sale to global organisations doing research in vaccine and drug development.
The breakthrough finding was published in the latest issue of the prestigious international peer-reviewed journal Cell Reports.
Influenza epidemics, such as the deadly 1918 Spanish Flu which killed over 50 million people or the severe acute respiratory syndrome (SARS) outbreak in 2002, are of big concern to governments and the general populace worldwide.
The World Health Organisation estimated that influenza results in about 3 to 5 million cases of severe illness worldwide each year, with about 250,000 to 500,000 deaths annually.
Pneumonia is the leading cause of death in children worldwide accounting for 15 per cent of all deaths for children under 5 years old, and is among the top 10 leading causes of death in the United States.
This new antibody was developed by NTU Singapore’s Associate Professor Andrew Tan, who led an interdisciplinary team of scientists from Singapore.
“While it will take up to eight years to develop the antibody into a useable treatment for human patients, we are currently developing a diagnostic kit which should be commercialised in about three years,” said Assoc Prof Tan.
“The kit will help doctors diagnose the severity of pneumonia and the efficacy of the prescribed treatment. This is done by detecting the concentration of a particular protein called ANGPTL4, which is present in samples taken from patients suffering from upper respiratory tract infections.”
The Latest on: Pandemics
via Google News
The Latest on: Pandemics
- Are We Entering a New Age of Pandemics?on October 14, 2021 at 1:09 am
The first age of pandemics followed in the wake of farming, cities and trade, because infections leverage proximity and numbers to survive and evolve. After millennia of mass mortality, followed by ...
- Pupils’ parallel pandemics in India and Tanzaniaon October 13, 2021 at 8:00 pm
The coronavirus pandemic has set back pupils’ learning further, closing schools. Limited access to mobile devices and the internet is a barrier to studying remotely. The FT followed two children ...
- Funding shortage puts future fight against pandemics at riskon October 13, 2021 at 7:57 pm
The Global Fund to Fight AIDS, Tuberculosis and Malaria announces it has awarded to date a total of $4 billion to more than 100 low- and middle-income countries to fight COVID-19, adapt Human ...
- WHO Unveils Proposed Team of Scientists Who Will 'Prevent Future Pandemics'on October 13, 2021 at 11:27 am
The World Health Organization unveiled Wednesday a proposed team of scientists tasked with looking at new pathogens and preventing future pandemics -- plus reviving the stalled probe into Covid-19's ...
- Past Pandemics Remind Us Covid Will Be an Era, Not a Crisis That Fadeson October 12, 2021 at 8:37 am
We tend to think of pandemics and epidemics as episodic,” said Allan Brandt, a historian of science and medicine at Harvard University. “But we are living in the Covid-19 era, not the Covid-19 crisis.
- Living through two pandemics: Kingston University research into experiences of HIV-positive people during Covid-19on October 12, 2021 at 7:51 am
The global response to two major health crises in recent history – the HIV pandemic and Covid-19 – and the experiences of people who lived through ...
- Soledad O’Brien speaks at 2021 DEI Virtual Summit on ‘parallel pandemics’ of racism and COVID-19on October 11, 2021 at 7:57 pm
The University of Michigan’s sixth annual DEI Summit convened Monday to discuss structural racism, COVID-19 pandemic ...
- Scientists are using AI originally developed for producing deepfake videos to stop future pandemicson October 11, 2021 at 4:54 pm
Generative adversarial networks are being used to predict the structure of antibodies that could neutralize a previously unknown virus ...
- Banks more worried about hackers than pandemics, survey findson October 10, 2021 at 1:43 am
The Bank of England surveyed bankers and others in the financial sector, finding that three in four are worried about cyber attacks.
- Vaccines Can’t End Pandemics Alone—And We’ve Known That Since We Eradicated Smallpoxon October 5, 2021 at 1:15 pm
President Thomas Jefferson in 1806 wrote a letter to English physician Edward Jenner. Ten years earlier, Jenner had intentionally infected a boy with cowpox, in order to protect him against the much ...
via Bing News